Metrics to compare | LUMITO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUMITOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −3.2x | −0.4x | |
PEG Ratio | 0.00 | −0.19 | 0.00 | |
Price/Book | 0.1x | 1.0x | 2.6x | |
Price / LTM Sales | - | 3.3x | 3.0x | |
Upside (Analyst Target) | - | 0.0% | 51.5% | |
Fair Value Upside | Unlock | 0.9% | 8.8% | Unlock |
Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. The company offers SCIZYS Erbium Kit, an upconverting nanoparticle (UCNP) based IHC kit that enables the identification of biotinylated primary or secondary antibodies in histological samples; SCIZYS S1, a whole slide imaging scanner that images histological samples using brightfield and UCNPs to display both chromogenic counterstaining and UCNP luminescence; and Katana Viewer, the file output format from SCIZYS, OME-TIFF can be used with any software platform. Its products can be used in drug development, academic research, and clinical diagnostics applications. Lumito AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden.